Inovio Pharmaceuticals, Inc. (INO) stock

Pharmaceutical Preparations

Inovio Pharmaceuticals, Inc. (INO) stock: what's happening now, every material event decoded in plain English, P/E and valuation, analyst ratings, and insider buying and selling.

What’s happening with Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. (INO) analyst ratings & price target

Consensus: Buy from 17 analysts (Buy 10 · Hold 5 · Sell 2).

Average price target: $2.75 (+57.6% vs $1.75); range $2–$3.

Wall Street analyst consensus, shown as context — not an AllSight view.

Inovio Pharmaceuticals, Inc. news, decoded

Inovio Pharmaceuticals, Inc. (INO) Stock — News, Financials & Insider Trading
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.